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ABSTRACT:
Devic's disease or Neuromyelitis Optica is a serious, rare idiopathic neurological disorder which affects the optic nerve
and the spinal cord. A 15-year-old girl was admitted in the neurology was with a previous history of 4 episodes of
weakness in both the lower limbs and urinary retention. The patient gradually lost her eyesight in both eyes at the age
of 8. Initially, she was diagnosed as a case of Multiple Sclerosis at the age of 11 when she presented with first episode
of lower limb weakness. Later, Seropositivity for Aquaporin 4 IgG and clear MRI scan of the brain confirmed the
diagnosis of Neuromyelitis Optica.

Case Report:
Devic's disease or Neuromyelitis Optica is a serious, a
rare idiopathic inflammatory neurological disorder
which affects the optic nerve and the spinal cord. It is a
severe demyelinating disorder of the nervous system
characterized by recurrent attacks on the optic nerve
and spinal cord with or without recovery and maybe
fatal (1) In most cases, the etiology of Neuromyelitis
Optica isn’t specific and it is believed to be an
immunological disorder (2). A few studies have detected
high titers of anti-Epstein-Barr virus (3) antibody in
patients suffering from the disease and a possible
association with tuberculosis (4) Neuromyelitis Optica
has worldwide distribution and poor prognosis. It
causes a sudden or gradual loss of vision in one or both
eyes, varying degrees of weakness or paralysis of legs
or arms, loss of sensation and bladder and bowel
dysfunction. Originally the disorder was considered to
be a variant of multiple sclerosis (MS), but clinical,
pathological, radiological and immunological data of
this disease have permitted clearer differences
between both the diseases and lead to a novel
definition of this clinical entity (5) The course of NMO is
more severe and treatment strategies to prevent further
attacks are different, therefore, it is important to
differentiate between NMO and MS. Immunotherapy to
prevent relapses of MS does not effectively prevent
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recurrent NMO attacks (6). The advent of NMO antibody,
the specific biomarker AQP4-IgG, is an additional
criterion to support the diagnosis of NMO (sensitivity
and specificity is 91% and 100%) (7)
CASE PRESENTATION:
We present here a case of a 15-year-old female
patient, coming from a poor socioeconomic
background, complaining of weakness in the lower
limbs and urine retention. The medical history of our
patient includes a gradual loss of vision at the age of 8
over the course of 3 years, losing her vision completely
at the age of 11. No neurological diseases were
reported in the family. The patient was hospitalized
before in 2015 due to weakness in the lower limbs and
facial droop. MRI scan of the brain showed no lesions.
Fundus examination showed bilateral optic atrophy.
(Figure. 1.0) Intermittent generalized slow waves were
seen throughout the EEG record. She was treated with
methylprednisolone and diagnosed with multiple
sclerosis at the time and discharged. At this time she
wasn’t on an disease modifying therapy. The patient’s
financial constraints have been a great hurdle in the
diagnosis and management of her condition.
with fever, headache, joint and muscle pain, and
decreased platelets (thrombocytopenia). It is caused by
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The patient was diagnosed with acute transverse
myelitis after observing the MRI results and
Neuromyelitis Optica was suspected. Advanced
immunological tests performed at Shifa International
Hospital
confirmed
the
presence
of
aquaporin-4-immunoglobulin G antibodies and the
patient was diagnosed with Neuromyelitis Optica as she
fulfilled both the major and minor diagnostic criterion of
the disease. Improvement in her symptoms was seen
after she was started on 5mg of prednisolone and went
through 5 plasmapheresis sessions.
The patient’s electrolytes were monitored regularly as
her lab reports showed low levels of potassium and
magnesium.
Neurological
examination
before
discharge showed grade 4 strength in her lower limbs
and she could walk with assistance. No improvement in
vision was observed.

Figure 1.0: Fundus examination showed bilateral
optic atrophy (encircled)
Her symptoms improved gradually, but ever since then
she has experienced varying degrees of paralysis in the
upper and lower limb, urinary retention and
constipation every year and has been hospitalized to
treat these symptoms Before being admitted here, she
has had admission 4 times previously in Government
Hospitals with no definitive diagnosis. The patient has
been prescribed carbamazepine, azathioprine, and
prednisolone to treat her spastic paraparesis episodes.
15 days ago, she presented to the hospital complaining
of progressive weakness in her legs, spasticity,
hyperreflexia and urine retention. On ophthalmological
examination, the absent pupillary light reflex was
observed. Ocular examination revealed the patient had
bilateral
nystagmus
(horizontal and coarse).

Figure 2: MRI - Spine showing the radiologic
finding of the patient T2-weighted MRI of the
thoracic spine revealed high-intensity signal
changes in the spinal cord involving both halves
extending from D2 to D9.
DISCUSSION
Through this study, we highlight the complexity of
diagnosing neuromyelitis optica and the treatment
challenges when socioeconomic factors are a hurdle.
Because of lack of funding in public hospitals,
plasmapheresis and the advanced immunological test
of NMO was delayed. Patients’ family was also
reluctant to go through these tests and procedures due
to financial constraints. The patient presented with
typical symptoms of NMO but was diagnosed as a case
of MS before she was presented to us. Differential
diagnosis between Longitudinal Extensive Transverse
Myelitis (LETM) that occurs in MS and NMO and SLE is
important since different therapeutic regimens are
required and interferon treatment may cause a flare-up
of the diseases (5,7,8). NMO is quite similar to the
optico-spinal form of MS hence it can be
misdiagnosed, however, the course of NMO is more
acute. Optic neuritis is severe with poor prognosis (9),
our patient had a very severe case of optic neuritis and
lost her vision irreversibly.
NMO Ig antibody is a highly specific diagnostic marker
for NMO. NMO is a rare pathological entity with
neurological manifestations. Previous literature
suggests that in patients’ with SLE or Sjogren’s
syndrome positive NMO IgG is not a secondary effect
but possibly these patients have two autoimmune
disorders (10,11). In other studies, the presence of NMO
IgG has been considered as a predictor for the
manifestation of NMO spectrum disorder and predicts

Her visual acuity had no
perception of light (NPL)
in both eyes and the
pupils were non-reactive
to light. Anterior segment
was normal in both eyes.
Neurological
exam
showed grade 5 strength
in upper limbs and grade
3 strength in the lower
limbs. The patient was vitally and hemodynamically
stable but her. T2-weighted MRI of the thoracic spine
revealed high-intensity signal changes in the spinal
cord involving both halves extending from D2 to D9.
Similar changes were noted in the cord at L1 and L2.
Diffuse edematous signals in entire cervico-dorsal cord
with mild post-contrast enhancement was observed on
T2 weighted MRI of the thoracic spine. (Figure. 2 There
was no cord swelling and focal thinning was seen in the
lower cervical cord.
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relapse of the disease. Co-existence of NMO is other
autoimmune disorders either organ-specific or
non-specific results in a poorer prognosis (12).

mofetil are the second line (14). However, it is unclear
that if NMO with other autoimmune disorders requires
different treatment regimens.

The current diagnostic criteria for NMO requires the
presence of optic neuritis and acute transverse myelitis
along with supportive criteria which include aquaporin 4
seropositivity
normal brain magnetic resonance
imaging or not meeting the criteria for multiple sclerosis
and longitudinally extensive cord lesion extending over
3 or more vertebral segments (7). Our patients
radiological and serums results fulfilled the diagnostic
criteria and all 3 supportive criteria were present.

The prognosis for NMO varies, studies have shown that
20% of the patient are functionally blind in one eye and
31% developed monoplegia/paraplegia. The 5-year
survival rate in patients with paraplegia was 91% (13)
CONCLUSION:
NMO is a rare but severe devastating disease affecting
vision and nervous system resulting in blindness and
paraplegia in children. Hence an early intervention with
the appropriate treatment modality in patients
suspected with NMO decides on the favorable outcome
from an acute episode.

The common initial therapy for acute attacks of NMO is
intravenous corticosteroids. In some studies, total
remission was obtained after prednisolone treatment.
Patients who do not benefit from corticosteroid therapy
may benefit from plasmapheresis (7). Our patient went
through 5 plasmapheresis sessions and was given 5
mg of prednisolone during her stay. The first line
therapy suggested for NMO is azathioprine combined
with
prednisolone
and
rituximab
whereas
cyclophosphamide, mitoxantrone, and mycophenolate
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CONSENT:
Informed consent was taken prior to the writing of this
case report from the patient.
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